A 7-gene expression signature predicts immune microenvironment remodeling and neoadjuvant chemo-immunotherapy response in lung squamous cell carcinoma

NCI altered the TME and was linked to treatment response in LUSC. Identifying predictors of immunotherapy efficacy, such as <i>HOXC13</i>, provides potential strategies to overcome resistance in clinical practice.